COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: A case-control study

Michael Poyurovsky, Elena Michaelovsky, Amos Frisch, Gabriela Knoll, Ilan Amir, Boris Finkel, Feodor Buniak, Haggai Hermesh, Ronit Weizman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

This is the first study of a possible molecular genetic basis for schizophrenia with obsessive-compulsive disorder (OCD). We performed a case-control association study of the catechol-O-methyltransferase (COMT) Val158Met polymorphism in schizophrenia-OCD patients, OCD and healthy controls. One hundred and thirteen schizophrenia-OCD patients, 79 OCD patients and 171 control subjects were genotyped for the Val158Met polymorphism in the COMT gene. There was no significant difference in allele and genotype distribution of the COMT gene between schizophrenia-OCD patients and healthy controls. The low-activity Met allele and Met/Met genotype were more frequent in OCD men than in schizophrenia-OCD and control individuals. This difference, however, was not statistically significant following correction for multiple comparisons. These results do not support the hypothesis that the COMT Val158Met gene polymorphism is associated with liability to schizophrenia-OCD.

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalNeuroscience Letters
Volume389
Issue number1
DOIs
StatePublished - 25 Nov 2005

Keywords

  • Catechol-O- methyltransferase (COMT)
  • Functional polymorphism
  • Genetic association
  • Obsessive-compulsive disorder (OCD)
  • Schizophrenia

Fingerprint

Dive into the research topics of 'COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: A case-control study'. Together they form a unique fingerprint.

Cite this